MEDICLIN Aktiengesellschaft

MEDICLIN Aktiengesellschaft

5.40
EUR
+0.05
(+0.93%)
0.66EPS
8.12P/E
249.38MMarket Cap
Mar 25Next Earn

Total Valuation

EUR

As of September 30, 2026, MEDICLIN Aktiengesellschaft carries a market capitalization of 249.38M, placing it among publicly traded companies globally. Its enterprise value stands at 439.96M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap249.38M
Enterprise Value439.96M

Important Dates

MEDICLIN Aktiengesellschaft's next confirmed earnings release is scheduled for March 25, 2027.

Earnings Date3/25/2027

Share Statistics

As of September 30, 2026, MEDICLIN Aktiengesellschaft has 47.50M shares outstanding.

Shares Outstanding47.50M

Valuation Ratios

As of September 30, 2026, MEDICLIN Aktiengesellschaft trades at a trailing price-to-earnings ratio of 8.12. The price-to-sales ratio is 0.32, and the price-to-book ratio stands at 0.89.

PE Ratio8.12
PS Ratio0.32
PB Ratio0.89
P/TBV Ratio0.95
P/FCF Ratio5.14
P/OCF Ratio2.59

Enterprise Valuation

As of September 30, 2026, MEDICLIN Aktiengesellschaft trades at an EV/EBITDA multiple of 3.72 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.56 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 7.81 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. MEDICLIN Aktiengesellschaft trades at an EV/FCF ratio of 6.81, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 439.96M versus a market cap of 249.38M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.56
EV / EBITDA3.72
EV / EBIT7.81
EV / FCF6.81

Financial Position

As of September 30, 2026, MEDICLIN Aktiengesellschaft maintains a current ratio of 1.84, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 131.00, indicating elevated leverage, while an interest coverage ratio of 5.91 demonstrates adequate ability to service its debt obligations.

Current Ratio1.84
Quick Ratio1.02
Debt / Equity131.00
Debt / EBITDA3.11
Interest Coverage5.91

Financial Efficiency

EUR

Over the twelve months ended September 30, 2026, MEDICLIN Aktiengesellschaft posted a return on equity (ROE) of 11.78, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 6.40 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 3.49, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 6.88, useful for judging operating efficiency across full business cycles. The company generates approximately 78,380.89 in revenue per employee across its workforce of 9,996.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 20.11 indicates how many times MEDICLIN Aktiengesellschaft sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)11.78
Return on Assets (ROA)3.49
Return on Invested Capital (ROIC)6.40
Return on Capital Employed (ROCE)6.88
Revenue Per Employee78,380.89
Employee Count9,996.00
Inventory Turnover20.11

Taxes

EUR

Over the twelve months ended September 30, 2026, MEDICLIN Aktiengesellschaft recorded 9.02M in income tax expense. That works out to an effective tax rate of 22.27, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 40.49M, leaving 31.06M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax9.02M
Effective Tax Rate22.27

Stock Price Statistics

EUR

As of the close on November 17, 2026, MEDICLIN Aktiengesellschaft's stock has gained approximately 60.71% over the past 52 weeks.

52-Week Price Change60.71%
50-Day Moving Average4.89

Income Statement

EUR

Over the twelve months ended September 30, 2026, MEDICLIN Aktiengesellschaft generated 783.50M in revenue and converted that into 31.06M in net income, yielding earnings per share of 0.66. EBITDA reached 118.35M, while operating income came in at 56.34M.

Revenue783.50M
Gross Profit662.44M
Operating Income56.34M
Pretax Income40.49M
Net Income31.06M
EBITDA118.35M
EBIT56.34M
Earnings Per Share (EPS)0.66

Balance Sheet

EUR

As of September 30, 2026, MEDICLIN Aktiengesellschaft holds 178.00M in cash and equivalents against 367.67M in total debt, resulting in a net debt position of -91.72M. Total book value stands at 279.75M, with working capital of 148.08M providing operational flexibility.

Cash & Cash Equivalents178.00M
Total Debt367.67M
Net Debt-91.72M
Equity (Book Value)279.75M
Book Value Per Share5.89
Working Capital148.08M

Cash Flow

EUR

MEDICLIN Aktiengesellschaft produced 97.51M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -48.47M in capital expenditures, free cash flow totaled 49.04M - equivalent to 1.02 per share.

Operating Cash Flow97.51M
Capital Expenditures-48.47M
Free Cash Flow49.04M
FCF Per Share1.02

Margins

Over the twelve months ended September 30, 2026, MEDICLIN Aktiengesellschaft posted a gross margin of 84.55, reflecting its pricing power and cost economics. The operating margin of 7.19 and net profit margin of 3.96 provide insight into operational efficiency.

Gross Margin84.55
Operating Margin7.19
Pretax Margin5.17
Profit Margin3.96
EBITDA Margin15.11

Dividends & Yields

Over the twelve months ended September 30, 2026, MEDICLIN Aktiengesellschaft paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 19.45, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 39.36, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to MEDICLIN Aktiengesellschaft shareholders.

Shareholder Yield39.36
FCF Yield19.45

Stock Splits

MEDICLIN Aktiengesellschaft's most recent stock split took place on November 25, 2008.

Last Split Date11/25/2008

Scores

As of September 30, 2026, MEDICLIN Aktiengesellschaft has an Altman Z-Score of 1.70, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.70